Position in CRON
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$797,712
-$133,651 QoQ
Shares Held
286,947
-22.7% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#30
of 192 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRON Over Time
Shares Held
Position Value (USD)
Derivatives in CRON
reported options exposure · as of Jun 30, 2026CallValue
$69,500
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $32,819,609 across 14 Drug Manufacturers - Specialty & Generic names. CRON ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
258,331 | $8,752,254 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
9,333 | $5,056,899 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
29,500 | $4,971,930 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
40,000 | $3,311,200 | |
| 5 | PRGO |
PERRIGO Co plc
|
253,459 | $2,633,439 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
25,000 | $1,598,750 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
197,863 | $1,567,074 | |
| 8 | EOLS |
Evolus, Inc.
|
216,316 | $1,501,233 |
All Filings in CRON
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $797,712 | 286,947 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $69,500 | 25,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $931,363 | 371,061 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $331,117 | 125,900 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $1,195,758 | 454,661 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $289,300 | 110,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $2,208,899 | 794,568 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $7,325,300 | 2,635,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $278,000 | 100,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $248,462 | 130,085 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $191,000 | 100,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $425,350 | 235,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $163,624 | 90,400 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50,500 | 25,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $435,673 | 215,680 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $979,700 | 485,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $219,000 | 100,000 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $493,389 | 225,292 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $762,558 | 348,200 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $1,044,306 | 448,200 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $582,500 | 250,000 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $503,261 | 215,992 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,187,550 | 455,000 | Call | Sole | 2024-05-15 | |
| 2021-03-31 | $473,000 | 50,000 | Put | Sole | 2021-05-17 | |
| 2021-03-31 | $1,419,000 | 150,000 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $347,000 | 50,000 | Put | Sole | 2021-02-16 | |
| 2020-12-31 | $1,041,000 | 150,000 | Call | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||